A study published in the journal Circulation shows that injecting microbubbles into the blood streams of mice and human subjects and then performing an ultrasound on a leg can increase blood flow, which could promote healing and save limbs from amputation.
Kent Thornburg, Ph.D., has taken an unconventional approach to fighting chronic disease. On any given day, you can find him evangelizing this tenet: your risk for chronic diseases such as heart disease was determined before you were even born. As part of American Diabetes Association Alert Day and National Nutrition Month, read what he has to say about the biggest threats to good nutrition and heart health.
Oregonians with serious illness or frailty are more likely to have their end-of-life care wishes honored, less likely to be hospitalized, and more likely to use home hospice services than the rest of the country.
The Zika virus attacks tissues in the nervous system, male and female reproductive and urinary tracts, muscles, joints and lymph nodes, and persists for at least 35 days, according to a study conducted in a nonhuman primate model by a multidisciplinary team of researchers at OHSU in Portland, Oregon.
Physicians in the Pacific Northwest Evidence-based Practice Center at OHSU in Portland, Oregon, played a critical role in updating recommendations for the Women’s Preventive Services Guidelines, which address a wide variety of unique health issues women face.
Approximately 40,000 babies are born each year in the United States with a congenital heart defect -- the most common type of birth defect -- but there’s good news: babies born with heart defects are living longer and healthier lives.
A first-of-its-kind vaccine technology platform developed by renowned scientists at OHSU in Portland, Oregon, has been acquired by Vir Biotechnology, a San Francisco-based biotech startup backed by leading industry investor ARCH Venture Partners and the Bill & Melinda Gates Foundation, a leading funder of global health initiatives.